Skip to main content
This block is broken or missing. You may be missing content or you might need to enable the original module.
Search
Main sub menu
Investors
Careers
Working at Recipharm
The Recipharm story
Meet our employees
Current vacancies
Contact
Contact us
Development services contacts
Manufacturing services contacts
Locations
Main navigation
Development
Drug substance
Drug product
Analytical chemistry
Clinical trial material (CTM)
Manufacturing
Solids
Semi-solids
Liquids
Inhalation
Injectables
Ophthalmics
Solutions
Recipharm Pathway to Clinic®
Serialisation
Learn
Press & events
Press
Events
Reports
Insights
Our story
Recipharm in brief
Business model
Business overview
Sustainability
Company history
Press & events
What's happening?
Stay updated on our latest news and events.
Press and Event
Press
Events
Reports
Insights
Displaying 1 - 10 of 44
Subscribe
Show all
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
Press
Announcement of prospectus regarding the admission to trading of new shares in Recipharm issued in connection with the acquisition of Lusomedicamenta
2014.12.22
Read more
Press
Customer to transfer Swedish penicillin manufacturing
2014.12.04
Read more
Press
Recipharm completes acquisition of Flamel Technologies facility in France
2014.12.01
Read more
Press
Change in the total number of shares and votes in Recipharm AB (publ)
2014.11.28
Read more
Press
Recipharm acquires Flamel Technologies facility and extend development services in France
2014.11.27
Read more
Press
Recipharm sponsors award for best doctoral thesis
2014.11.19
Read more
Press
Invitation to telephone conference due to Recipharm’s acquisition of Lusomedicamenta
2014.11.14
Read more
Press
Recipharm acquires Lusomedicamenta for SEK 1 billion
2014.11.13
Read more
Press
Interim report January-September 2014
2014.11.07
Read more
Press
Interim report January-September 2014
2014.11.07
Read more
Pagination
Current page
1
Page
2
Page
3
Page
4
Page
5
Next page
Next ›
Last page
Last »
